Treace Medical Concepts (TMCI) Market Capitalization (2021 - 2026)

Treace Medical Concepts (TMCI) has reported Market Capitalization for 6 consecutive years, with $258.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 30.32% year-over-year to $258.8 million; the trailing twelve-month figure through Jun 2026 stood at $258.8 million (down 30.32% YoY), and the FY2025 full-year result was $158.2 million, down 66.03% from the prior year.
• Market Capitalization grew to $258.8 million in Q2 2026 per TMCI's latest filing, from $86.9 million in the prior quarter.
• Across five years, Market Capitalization topped out at $1.8 billion in Q3 2022 and bottomed at $86.9 million in Q1 2026.
• Historically, Market Capitalization has averaged $802.9 million across 5 years, with a median of $657.5 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Market Capitalization surged 32.55% in 2023, then sank 83.53% in 2026.
• Over 5 years, Market Capitalization stood at $1.3 billion in 2022, then sank by 38.44% to $787.3 million in 2023, then sank by 40.83% to $465.9 million in 2024, then sank by 66.03% to $158.2 million in 2025, then soared by 63.57% to $258.8 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $258.8 million, $86.9 million, and $158.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.